Maintenance Intravenous Iron Therapy in Hepmodialysis Patients Receiving Recombinant Human Erythropoientin
Iron Supplementation is crucial in raising hematocrit as well as dosage saving for recombinant human erythropoietin therapy (rHuEPO) in maintenance hemodialysis patients. Intravenous iron has proved to be both safe and efficacious in this patient′s population. However, the exact iron requ...
Main Authors: | Romeh Saleh, Huraib Sameer, Murray Noeline, Tanimu Danlami, Flaiw Ahmed, Iqbal Asmir, Al Ghamdi Ghormullah, Quadri Khaja |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
1999-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Subjects: | |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=1999;volume=10;issue=1;spage=21;epage=25;aulast=Romeh |
Similar Items
-
Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients
by: Huixin Chen, et al.
Published: (2023-07-01) -
To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period
by: Akriti Gupta, et al.
Published: (2022-12-01) -
The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients
by: Xinju Zhao, et al.
Published: (2024-12-01) -
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
by: Dae Woong Kang, et al.
Published: (2012-03-01) -
Higher dose of erythropoietin for anemia correction in Balkan endemic nephropathy patients
by: Lukić Ljiljana, et al.
Published: (2012-01-01)